An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease
Background: Worldwide, diabetic kidney disease (DKD) remains the leading cause of chronic kidney disease (CKD) and its successor, the end stage renal disease, both of which constitute major morbidity and mortality concerns. Content: The residual risk of disease progression remains despite the advert...
| Үндсэн зохиолчид: | , , , |
|---|---|
| Формат: | Өгүүллэг |
| Хэвлэсэн: |
Malaysian Society of Pathologists
2022
|
| _version_ | 1825938336845398016 |
|---|---|
| author | Zahari Sham, Siti Yazmin Abdullah, Maha Osman, Malina Seow, Heng Fong |
| author_facet | Zahari Sham, Siti Yazmin Abdullah, Maha Osman, Malina Seow, Heng Fong |
| author_sort | Zahari Sham, Siti Yazmin |
| collection | UPM |
| description | Background: Worldwide, diabetic kidney disease (DKD) remains the leading cause of chronic kidney disease (CKD) and its successor, the end stage renal disease, both of which constitute major morbidity and mortality concerns. Content: The residual risk of disease progression remains despite the advert of newer therapeutic modalities and current biomarkers. Meanwhile, microRNAs (miRNAs) are small non-coding RNAs, which regulate gene expression post-translationally by binding to specific mRNAs. Circulating miRNAs are increasingly recognised as novel biomarker or therapeutic targets, owing to their unique characteristics, such as their resilience to degradation by endogenous RNases, multiple downstream targets, involvement in biological processes, some degree of tissue specificity, relatively easy access and quantification. Unlike proteins, there are far less miRNAs and mature miRNAs are highly stable, structurally less complex without post-translational modification with high degree of conservation across species. Aberrant expression of miRNAs has been established in both in vitro and in vivo models of DKD. An up-to-date compilation of previous studies involving selected circulating miRNAs in blood and urine samples of DKD patients is discussed herein. Summary: This review highlights the unmet clinical challenges and dysregulation of miRNAs in the pathogenesis of DKD. |
| first_indexed | 2024-09-25T03:36:25Z |
| format | Article |
| id | upm.eprints-100256 |
| institution | Universiti Putra Malaysia |
| last_indexed | 2024-09-25T03:36:25Z |
| publishDate | 2022 |
| publisher | Malaysian Society of Pathologists |
| record_format | dspace |
| spelling | upm.eprints-1002562024-07-09T02:36:03Z http://psasir.upm.edu.my/id/eprint/100256/ An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease Zahari Sham, Siti Yazmin Abdullah, Maha Osman, Malina Seow, Heng Fong Background: Worldwide, diabetic kidney disease (DKD) remains the leading cause of chronic kidney disease (CKD) and its successor, the end stage renal disease, both of which constitute major morbidity and mortality concerns. Content: The residual risk of disease progression remains despite the advert of newer therapeutic modalities and current biomarkers. Meanwhile, microRNAs (miRNAs) are small non-coding RNAs, which regulate gene expression post-translationally by binding to specific mRNAs. Circulating miRNAs are increasingly recognised as novel biomarker or therapeutic targets, owing to their unique characteristics, such as their resilience to degradation by endogenous RNases, multiple downstream targets, involvement in biological processes, some degree of tissue specificity, relatively easy access and quantification. Unlike proteins, there are far less miRNAs and mature miRNAs are highly stable, structurally less complex without post-translational modification with high degree of conservation across species. Aberrant expression of miRNAs has been established in both in vitro and in vivo models of DKD. An up-to-date compilation of previous studies involving selected circulating miRNAs in blood and urine samples of DKD patients is discussed herein. Summary: This review highlights the unmet clinical challenges and dysregulation of miRNAs in the pathogenesis of DKD. Malaysian Society of Pathologists 2022-08 Article PeerReviewed Zahari Sham, Siti Yazmin and Abdullah, Maha and Osman, Malina and Seow, Heng Fong (2022) An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease. Malaysian Journal of Pathology, 44 (2). pp. 187-201. ISSN 0126-8635 https://www.mjpath.org.my/2022/v44n2/index.php |
| spellingShingle | Zahari Sham, Siti Yazmin Abdullah, Maha Osman, Malina Seow, Heng Fong An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease |
| title | An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease |
| title_full | An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease |
| title_fullStr | An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease |
| title_full_unstemmed | An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease |
| title_short | An insight of dysregulation of microRNAs in the pathogenesis of diabetic kidney disease |
| title_sort | insight of dysregulation of micrornas in the pathogenesis of diabetic kidney disease |
| work_keys_str_mv | AT zaharishamsitiyazmin aninsightofdysregulationofmicrornasinthepathogenesisofdiabetickidneydisease AT abdullahmaha aninsightofdysregulationofmicrornasinthepathogenesisofdiabetickidneydisease AT osmanmalina aninsightofdysregulationofmicrornasinthepathogenesisofdiabetickidneydisease AT seowhengfong aninsightofdysregulationofmicrornasinthepathogenesisofdiabetickidneydisease AT zaharishamsitiyazmin insightofdysregulationofmicrornasinthepathogenesisofdiabetickidneydisease AT abdullahmaha insightofdysregulationofmicrornasinthepathogenesisofdiabetickidneydisease AT osmanmalina insightofdysregulationofmicrornasinthepathogenesisofdiabetickidneydisease AT seowhengfong insightofdysregulationofmicrornasinthepathogenesisofdiabetickidneydisease |